ArticlePharmaceutical research2023

Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.

Emily Briggs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.